4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000108
Chairperson & CEO sold 9,500 shares at an average $526.73 ($5,003,976)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-28 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $135.42 | $1,286,490 | 333,943 | I |
| 2026-07-28 | Sale : show line 2 in the form 10b5-1 | −1,367 | $523.15 | $715,152 | 332,576 | I |
| 2026-07-28 | Sale : show line 3 in the form 10b5-1 | −1,074 | $524.04 | $562,818 | 331,502 | I |
| 2026-07-28 | Sale : show line 4 in the form 10b5-1 | −876 | $525.02 | $459,918 | 330,626 | I |
| 2026-07-28 | Sale : show line 5 in the form 10b5-1 | −1,473 | $526.34 | $775,295 | 329,153 | I |
| 2026-07-28 | Sale : show line 6 in the form 10b5-1 | −1,369 | $527.16 | $721,678 | 327,784 | I |
| 2026-07-28 | Sale : show line 7 in the form 10b5-1 | −1,149 | $528.20 | $606,905 | 326,635 | I |
| 2026-07-28 | Sale : show line 8 in the form 10b5-1 | −625 | $529.41 | $330,882 | 326,010 | I |
| Open-market sales · 9,500 sh · avg $526.73 · $5,003,976 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-28 | Exercise or conversion : show line 12 in the form 10b5-1 Stock Option | −9,500 | 255,910 | I |
Loading xslF345X06/primarydocument.xml…